Stock Analysis
- France
- /
- Diversified Financial
- /
- ENXTPA:RF
Top Growth Companies With High Insider Ownership On Euronext Paris August 2024
Reviewed by Simply Wall St
As the Eurozone economy maintains its resilience, the French CAC 40 Index has seen a notable advance of 2.48%, reflecting growing optimism among investors. In this favorable market environment, growth companies with high insider ownership are particularly compelling due to their potential for robust performance driven by strong internal confidence and alignment of interests. In this article, we will explore three top growth companies listed on Euronext Paris that exhibit significant insider ownership as of August 2024.
Top 10 Growth Companies With High Insider Ownership In France
Name | Insider Ownership | Earnings Growth |
Groupe OKwind Société anonyme (ENXTPA:ALOKW) | 24.8% | 36% |
VusionGroup (ENXTPA:VU) | 13.4% | 25.7% |
Adocia (ENXTPA:ADOC) | 11.9% | 63% |
Icape Holding (ENXTPA:ALICA) | 30.2% | 35.1% |
Arcure (ENXTPA:ALCUR) | 21.4% | 27.5% |
La Française de l'Energie (ENXTPA:FDE) | 19.9% | 31.9% |
STIF Société anonyme (ENXTPA:ALSTI) | 16.4% | 28.5% |
Munic (ENXTPA:ALMUN) | 29.2% | 149.2% |
OSE Immunotherapeutics (ENXTPA:OSE) | 25.6% | 5.9% |
MedinCell (ENXTPA:MEDCL) | 15.8% | 71.1% |
Let's dive into some prime choices out of the screener.
MedinCell (ENXTPA:MEDCL)
Simply Wall St Growth Rating: ★★★★★☆
Overview: MedinCell S.A., a pharmaceutical company based in France, specializes in developing long-acting injectables across various therapeutic areas and has a market cap of €511.36 million.
Operations: MedinCell generates €11.95 million in revenue from its pharmaceuticals segment.
Insider Ownership: 15.8%
MedinCell, a French growth company with high insider ownership, reported a net loss of €25.04 million for the fiscal year ending March 31, 2024, an improvement from the previous year's €32.01 million loss. Despite declining sales and revenue, the company's revenue is forecast to grow at 44.7% annually and become profitable within three years. Trading at 87.2% below its estimated fair value highlights potential investment opportunities amidst its current negative shareholders' equity situation.
- Get an in-depth perspective on MedinCell's performance by reading our analyst estimates report here.
- Our comprehensive valuation report raises the possibility that MedinCell is priced higher than what may be justified by its financials.
OVH Groupe (ENXTPA:OVH)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: OVH Groupe S.A. offers public and private cloud services, shared hosting, and dedicated server solutions globally, with a market cap of €1.12 billion.
Operations: The company's revenue segments include €169.01 million from public cloud, €589.61 million from private cloud, and €185.43 million from web cloud services.
Insider Ownership: 10.5%
OVH Groupe, trading 32.4% below its estimated fair value, is forecast to become profitable within three years with earnings expected to grow 101.12% annually. Despite a volatile share price and lower-than-benchmark return on equity forecasts (1.7%), OVH's revenue growth at 10% per year outpaces the French market average of 5.8%. Recent innovations include new AMD EPYC-powered Bare Metal Advance servers, enhancing performance and offering robust support for various business workloads.
- Navigate through the intricacies of OVH Groupe with our comprehensive analyst estimates report here.
- Our valuation report unveils the possibility OVH Groupe's shares may be trading at a discount.
Eurazeo (ENXTPA:RF)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Eurazeo SE is a private equity and venture capital firm that focuses on growth capital, acquisitions, leveraged buyouts, and investments in mid-market and listed public companies, with a market cap of €5.16 billion.
Operations: Eurazeo SE generates revenue through its private equity and venture capital activities, specializing in growth capital, acquisitions, leveraged buyouts, and investments in both mid-market and listed public companies.
Insider Ownership: 12.1%
Eurazeo, trading at 84% below its estimated fair value, is forecast to achieve 47.4% annual revenue growth, significantly outpacing the French market's 5.8%. Expected to become profitable within three years with earnings projected to grow 49.87% annually, it has recently completed a €109 million share buyback. Despite strong growth prospects, recent half-year results showed a net loss of €104.56 million compared to last year's net income of €1.80 billion and an unsustainable dividend yield of 3.39%.
- Click here to discover the nuances of Eurazeo with our detailed analytical future growth report.
- Our valuation report here indicates Eurazeo may be undervalued.
Key Takeaways
- Investigate our full lineup of 23 Fast Growing Euronext Paris Companies With High Insider Ownership right here.
- Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
- Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
Ready For A Different Approach?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Eurazeo might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ENXTPA:RF
Eurazeo
A private equity and venture capital firm specializing in growth capital, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in mid-market and listed public companies.